REVIEW 2 cited by
API-BLEND: A Comprehensive Corpora for Training and Benchmarking API LLMs
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
There is a growing need for Large Language Models (LLMs) to effectively use tools and external Application Programming Interfaces (APIs) to plan and complete tasks. As such, there is tremendous interest in methods that can acquire sufficient quantities of train and test data that involve calls to tools / APIs. Two lines of research have emerged as the predominant strategies for addressing this challenge. The first has focused on synthetic data generation techniques, while the second has involved curating task-adjacent datasets which can be transformed into API / Tool-based tasks. In this paper, we focus on the task of identifying, curating, and transforming existing datasets and, in turn, introduce API-BLEND, a large corpora for training and systematic testing of tool-augmented LLMs. The datasets mimic real-world scenarios involving API-tasks such as API / tool detection, slot filling, and sequencing of the detected APIs. We demonstrate the utility of the API-BLEND dataset for both training and benchmarking purposes.
Forward citations
Cited by 2 Pith papers
-
DICE-BENCH: Evaluating the Tool-Use Capabilities of Large Language Models in Multi-Round, Multi-Party Dialogues
A new benchmark and metric show that large language models still struggle to call tools when the needed details are scattered across multi-party, multi-round group dialogues.
-
An Auditable Agent Platform For Automated Molecular Optimisation
A hierarchical multi-agent LLM platform with recorded provenance improved average predicted binding affinity for AKT1 by 31%, while single-agent runs favored drug-likeness.
Discussion (0). Sign in to comment.